Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Fuller, Smith & Turner PLC (FSTA)
Fuller, Smith & Turner P.L.C. (“the Company”)
Director/PDMR Shareholdings
This notification is made in accordance with the Market Abuse Regulation.
The Company annnounces that on 28 June 2024 the Executive Directors and persons discharging managerial responsibilities (“PDMRs”) detailed below were granted conditional share awards under the Company’s Bonus and Deferred Bonus Plan 2019 (the ”BDBP”) and/or the Company’s Long-Term Incentive Plan 2020 (the “LTIP”).
The calculation of the awards is based on the five day average price of the middle market quotations ending 27 June 2024 being £6.956 for ‘A’ Ordinary Shares.
All awards are over a combination of both 40p ‘A’ Ordinary Shares and 4p ‘B’ Ordinary Shares. The calculation of the awards is based on the five day average price of the middle market quotations ending 27 June 2024, being £6.956 for ‘A’ Ordinary Shares and £0.6956 (notionally) for ‘B’ Ordinary Shares.
Vesting of these awards is subject to the fulfilment of certain performance conditions over the three-year period ending FY2027 (as detailed in the 2024 Annual Report and Accounts) and continued employment. All awards granted to Executive Directors are subject to a two-year holding period. Under the Plan rules, the Remuneration Committee has full discretion to ensure that the final outturn reflects all relevant factors, including consideration of any windfall gains.
Enquiries: Rachel Spencer Company Secretary 020 8996 2073
2 July 2024
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. |
ISIN: | GB00B1YPC344 |
Category Code: | DSH |
TIDM: | FSTA |
LEI Code: | 213800C7ACOFMRCQQW76 |
OAM Categories: | 3.1. Additional regulated information required to be disclosed under the laws of a Member State |
Sequence No.: | 331610 |
EQS News ID: | 1938135 |
End of Announcement | EQS News Service |
UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.